{"ABC": {"Ticker": "ABC", "Company": "AmerisourceBergen", "Sector": "Health Care", "Updated": "2022-04-01", "Rating": [{"Date": "2022-04-01", "Rating": "Resumed", "Organization": "Credit Suisse", "Rating_Change": "Outperform", "Target_Change": "$180"}], "Score": 2.0, "Cumulative_Rating": "Significant Outperform", "Number_of_Analysts": 1, "Period": "180 days", "Analists": ["Credit Suisse"], "Price_Target": 180.0}, "CAH": {"Ticker": "CAH", "Company": "Cardinal Health", "Sector": "Health Care", "Updated": "2022-04-01", "Rating": [{"Date": "2022-04-01", "Rating": "Resumed", "Organization": "Credit Suisse", "Rating_Change": "Neutral", "Target_Change": "$58"}], "Score": 0.0, "Cumulative_Rating": "Neutral", "Number_of_Analysts": 1, "Period": "180 days", "Analists": ["Credit Suisse"], "Price_Target": 58.0}, "CMA": {"Ticker": "CMA", "Company": "Comerica", "Sector": "Financials", "Updated": "2022-04-01", "Rating": [{"Date": "2022-04-01", "Rating": "Upgrade", "Organization": "JP Morgan", "Rating_Change": "Neutral to Overweight", "Target_Change": "$108 to $115"}, {"Date": "2022-04-01", "Rating": "Upgrade", "Organization": "Goldman", "Rating_Change": "Sell to Neutral", "Target_Change": "$102 to $112"}, {"Date": "2022-03-24", "Rating": "Resumed", "Organization": "Citigroup", "Rating_Change": "Buy", "Target_Change": ""}, {"Date": "2022-02-16", "Rating": "Upgrade", "Organization": "Compass Point", "Rating_Change": "Neutral to Buy", "Target_Change": "$105 to $115"}, {"Date": "2022-02-14", "Rating": "Upgrade", "Organization": "Jefferies", "Rating_Change": "Hold to Buy", "Target_Change": "$98 to $114"}, {"Date": "2022-01-07", "Rating": "Downgrade", "Organization": "Robert W. Baird", "Rating_Change": "Neutral to Underperform", "Target_Change": "$78"}, {"Date": "2022-01-06", "Rating": "Upgrade", "Organization": "BofA Securities", "Rating_Change": "Underperform to Neutral", "Target_Change": "$88 to $105"}], "Score": 1.14, "Cumulative_Rating": "Outperform", "Number_of_Analysts": 7, "Period": "180 days", "Analists": ["BofA Securities", "Robert W. Baird", "Jefferies", "Citigroup", "Compass Point", "JP Morgan", "Goldman"], "Price_Target": 90.29}, "GPS": {"Ticker": "GPS", "Company": "Gap", "Sector": "Consumer Discretionary", "Updated": "2022-04-01", "Rating": [{"Date": "2022-04-01", "Rating": "Downgrade", "Organization": "Barclays", "Rating_Change": "Equal Weight to Underweight", "Target_Change": "$17 to $13"}, {"Date": "2022-03-09", "Rating": "Downgrade", "Organization": "Daiwa Securities", "Rating_Change": "Neutral to Underperform", "Target_Change": "$13.75"}, {"Date": "2022-02-15", "Rating": "Downgrade", "Organization": "BofA Securities", "Rating_Change": "Neutral to Underperform", "Target_Change": "$26 to $14"}, {"Date": "2022-02-03", "Rating": "Downgrade", "Organization": "Barclays", "Rating_Change": "Overweight to Equal Weight", "Target_Change": "$15"}, {"Date": "2022-01-18", "Rating": "Downgrade", "Organization": "Morgan Stanley", "Rating_Change": "Equal-Weight to Underweight", "Target_Change": "$20 to $14"}], "Score": -2.0, "Cumulative_Rating": "Significant Underperform", "Number_of_Analysts": 5, "Period": "180 days", "Analists": ["Daiwa Securities", "BofA Securities", "Barclays", "Morgan Stanley"], "Price_Target": 10.2}, "MCK": {"Ticker": "MCK", "Company": "McKesson Corporation", "Sector": "Health Care", "Updated": "2022-04-01", "Rating": [{"Date": "2022-04-01", "Rating": "Resumed", "Organization": "Credit Suisse", "Rating_Change": "Outperform", "Target_Change": "$333"}, {"Date": "2022-02-04", "Rating": "Downgrade", "Organization": "Deutsche Bank", "Rating_Change": "Buy to Hold", "Target_Change": "$262 to $270"}, {"Date": "2022-01-07", "Rating": "Upgrade", "Organization": "Credit Suisse", "Rating_Change": "Neutral to Outperform", "Target_Change": ""}], "Score": 1.0, "Cumulative_Rating": "Outperform", "Number_of_Analysts": 3, "Period": "180 days", "Analists": ["Credit Suisse", "Deutsche Bank"], "Price_Target": 200.0}, "MSCI": {"Ticker": "MSCI", "Company": "MSCI", "Sector": "Financials", "Updated": "2022-04-01", "Rating": [{"Date": "2022-04-01", "Rating": "Initiated", "Organization": "Goldman", "Rating_Change": "Neutral", "Target_Change": "$553"}, {"Date": "2022-03-30", "Rating": "Initiated", "Organization": "Deutsche Bank", "Rating_Change": "Hold", "Target_Change": "$533"}], "Score": 0.0, "Cumulative_Rating": "Neutral", "Number_of_Analysts": 2, "Period": "180 days", "Analists": ["Goldman", "Deutsche Bank"], "Price_Target": 543.0}, "ORCL": {"Ticker": "ORCL", "Company": "Oracle", "Sector": "Information Technology", "Updated": "2022-04-01", "Rating": [{"Date": "2022-04-01", "Rating": "Initiated", "Organization": "Daiwa Securities", "Rating_Change": "Neutral", "Target_Change": "$87"}, {"Date": "2022-03-29", "Rating": "Downgrade", "Organization": "Exane BNP Paribas", "Rating_Change": "Neutral to Underperform", "Target_Change": "$79"}, {"Date": "2022-03-11", "Rating": "Upgrade", "Organization": "Societe Generale", "Rating_Change": "Hold to Buy", "Target_Change": ""}, {"Date": "2022-03-11", "Rating": "Downgrade", "Organization": "Piper Sandler", "Rating_Change": "Neutral to Underweight", "Target_Change": "$100 to $70"}], "Score": -0.5, "Cumulative_Rating": "Neutral", "Number_of_Analysts": 4, "Period": "180 days", "Analists": ["Societe Generale", "Daiwa Securities", "Piper Sandler", "Exane BNP Paribas"], "Price_Target": 58.0}, "WBA": {"Ticker": "WBA", "Company": "Walgreens Boots Alliance", "Sector": "Consumer Staples", "Updated": "2022-04-01", "Rating": [{"Date": "2022-04-01", "Rating": "Downgrade", "Organization": "Robert W. Baird", "Rating_Change": "Outperform to Neutral", "Target_Change": "$70 to $51"}], "Score": -2.0, "Cumulative_Rating": "Significant Underperform", "Number_of_Analysts": 1, "Period": "180 days", "Analists": ["Robert W. Baird"], "Price_Target": 51.0}, "WYNN": {"Ticker": "WYNN", "Company": "Wynn Resorts", "Sector": "Consumer Discretionary", "Updated": "2022-04-01", "Rating": [{"Date": "2022-04-01", "Rating": "Upgrade", "Organization": "Citigroup", "Rating_Change": "Neutral to Buy", "Target_Change": "$98 to $96.50"}, {"Date": "2022-02-16", "Rating": "Reiterated", "Organization": "Wells Fargo", "Rating_Change": "Equal Weight", "Target_Change": "$93 to $99"}, {"Date": "2022-02-16", "Rating": "Reiterated", "Organization": "Morgan Stanley", "Rating_Change": "Overweight", "Target_Change": "$117 to $123"}, {"Date": "2022-02-16", "Rating": "Reiterated", "Organization": "JP Morgan", "Rating_Change": "Neutral", "Target_Change": "$93 to $102"}, {"Date": "2022-02-16", "Rating": "Reiterated", "Organization": "Deutsche Bank", "Rating_Change": "Buy", "Target_Change": "$131 to $121"}, {"Date": "2022-02-16", "Rating": "Reiterated", "Organization": "Citigroup", "Rating_Change": "Neutral", "Target_Change": "$94.50 to $98"}, {"Date": "2022-02-16", "Rating": "Reiterated", "Organization": "BofA Securities", "Rating_Change": "Neutral", "Target_Change": "$90 to $100"}, {"Date": "2022-01-11", "Rating": "Downgrade", "Organization": "Citigroup", "Rating_Change": "Buy to Neutral", "Target_Change": "$99 to $92.50"}], "Score": 0.62, "Cumulative_Rating": "Outperform", "Number_of_Analysts": 8, "Period": "180 days", "Analists": ["BofA Securities", "Wells Fargo", "Citigroup", "Deutsche Bank", "JP Morgan", "Morgan Stanley"], "Price_Target": 78.38}, "ZBH": {"Ticker": "ZBH", "Company": "Zimmer Biomet", "Sector": "Health Care", "Updated": "2022-04-01", "Rating": [{"Date": "2022-04-01", "Rating": "Downgrade", "Organization": "Citigroup", "Rating_Change": "Buy to Neutral", "Target_Change": "$125.15 to $135"}, {"Date": "2022-03-02", "Rating": "Resumed", "Organization": "BofA Securities", "Rating_Change": "Underperform", "Target_Change": "$120"}, {"Date": "2022-03-02", "Rating": "Downgrade", "Organization": "Loop Capital", "Rating_Change": "Buy to Hold", "Target_Change": "$130"}, {"Date": "2022-02-08", "Rating": "Reiterated", "Organization": "Wells Fargo", "Rating_Change": "Underweight", "Target_Change": "$124 to $111"}, {"Date": "2022-02-08", "Rating": "Reiterated", "Organization": "UBS", "Rating_Change": "Neutral", "Target_Change": "$130 to $121"}, {"Date": "2022-02-08", "Rating": "Reiterated", "Organization": "Truist", "Rating_Change": "Buy", "Target_Change": "$145 to $128"}, {"Date": "2022-02-08", "Rating": "Reiterated", "Organization": "Stifel", "Rating_Change": "Buy", "Target_Change": "$178 to $130"}, {"Date": "2022-02-08", "Rating": "Reiterated", "Organization": "RBC Capital Mkts", "Rating_Change": "Sector Perform", "Target_Change": "$140 to $125"}, {"Date": "2022-02-08", "Rating": "Reiterated", "Organization": "JP Morgan", "Rating_Change": "Neutral", "Target_Change": "$150 to $114"}, {"Date": "2022-02-08", "Rating": "Reiterated", "Organization": "JMP Securities", "Rating_Change": "Mkt Outperform", "Target_Change": "$175 to $145"}, {"Date": "2022-02-08", "Rating": "Reiterated", "Organization": "Deutsche Bank", "Rating_Change": "Hold", "Target_Change": "$140 to $121"}, {"Date": "2022-02-08", "Rating": "Reiterated", "Organization": "Citigroup", "Rating_Change": "Buy", "Target_Change": "$150 to $129"}, {"Date": "2022-02-08", "Rating": "Downgrade", "Organization": "Canaccord Genuity", "Rating_Change": "Buy to Hold", "Target_Change": "$165 to $125"}, {"Date": "2022-02-02", "Rating": "Downgrade", "Organization": "UBS", "Rating_Change": "Buy to Neutral", "Target_Change": "$172 to $130"}, {"Date": "2022-01-19", "Rating": "Downgrade", "Organization": "Wells Fargo", "Rating_Change": "Equal Weight to Underweight", "Target_Change": "$170 to $124"}, {"Date": "2022-01-10", "Rating": "Downgrade", "Organization": "Mizuho", "Rating_Change": "Buy to Neutral", "Target_Change": ""}, {"Date": "2022-01-07", "Rating": "Downgrade", "Organization": "Morgan Stanley", "Rating_Change": "Overweight to Equal-Weight", "Target_Change": "$165 to $145"}, {"Date": "2022-01-04", "Rating": "Downgrade", "Organization": "Piper Sandler", "Rating_Change": "Overweight to Neutral", "Target_Change": "$185 to $135"}], "Score": -0.22, "Cumulative_Rating": "Neutral", "Number_of_Analysts": 18, "Period": "180 days", "Analists": ["Piper Sandler", "Stifel", "BofA Securities", "Loop Capital", "Deutsche Bank", "UBS", "Wells Fargo", "Mizuho", "Canaccord Genuity", "JMP Securities", "Citigroup", "Truist", "RBC Capital Mkts", "JP Morgan", "Morgan Stanley"], "Price_Target": 119.44}}